Outcome, Fatal Clinical Trial
Official title:
GermanVasc/MDEpiNet Paclitaxel Study
The GermanVasc/MDEpiNet Paclitaxel Study, aims to use routinely collected data from health insurance claims and registries. The longitudinal data of Germany's second-largest insurance fund, BARMER, includes the outpatient and inpatient medical care provided to ≈9.4 million German citizens (13.2% of Germany's population) involving >21 million hospitalizations between January 1, 2008, and December 31, 2018. The BARMER cohort is similar to Western European countries and has been widely used for research projects. A regular random sample validation of internal and external validity is performed by the Medical Service of the Health Funds in Germany, and various peer-reviewed validation studies have been previously published. The GermanVasc clinical registry was implemented in 2018 as EU General Data Protection Regulation (GDPR) compliant registry platform to process routinely collected clinical data from more than 35 high-volume vascular centers in Germany. In an ongoing project of a large multispecialty and multidisciplinary research consortium (RABATT study, Principal Investigator: PD Dr. Christian-Alexander Behrendt), active surveillance and medical device evaluation methods were developed. The current study aims to determine the long-term safety and efficacy of paclitaxel-coated balloons and stents in peripheral arteries. It further aims to illuminate the underlying differences between the cohorts in randomized controlled trials (RCT) and real-world data that can possibly explain the diametrically opposed results in an ongoing international controversy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04735055 -
Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
|
||
| Recruiting |
NCT06006975 -
Early Warning of Delayed Cerebral Ischemia
|
||
| Not yet recruiting |
NCT05983549 -
Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial
|
N/A | |
| Recruiting |
NCT05788861 -
Invasive Group A Streptococcal Infection
|
||
| Completed |
NCT03104946 -
To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants
|
N/A | |
| Not yet recruiting |
NCT04584463 -
Factors Associated With CPC 1-2 in 110 Patients Admitted in French ICU for a Myocardial Infarction Complicated by an OHCA.
|
||
| Completed |
NCT04235920 -
Cognitive Impairment and Outcome of Acute Ischemic Stroke.
|
||
| Not yet recruiting |
NCT04582188 -
The Early Coagulopathy for the Prognosis in Sepsis
|
||
| Completed |
NCT04260334 -
Preoperative Care In Ovarian Cancer Patients
|
N/A | |
| Recruiting |
NCT04121429 -
Stopping Cardiovascular Treatments and Mortality in a MICU
|
||
| Completed |
NCT05338593 -
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
|
||
| Not yet recruiting |
NCT04339322 -
Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt
|
||
| Completed |
NCT03619759 -
The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery
|
||
| Not yet recruiting |
NCT06146270 -
Russian Registry of Surgical OutcomeS
|
||
| Completed |
NCT04542954 -
Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
|
||
| Completed |
NCT04292964 -
Prognostic Factors of Patients With COVID-19
|
||
| Withdrawn |
NCT03228043 -
Apatinib for Resectable Colorectal Cancer
|
N/A | |
| Completed |
NCT03470571 -
CMR Features in Patients With Suspected Myocarditis
|
||
| Active, not recruiting |
NCT04293653 -
Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy
|
N/A | |
| Completed |
NCT02947698 -
Effect of Weekend Admission on Mortality Associated With Severe Acute Kidney Injury in England: a Propensity Score Matched, Population-based Study
|
N/A |